Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Mid-range Performer
1482.0000
-47.50
(
-3.11
%)
NSE
Jul 31, 2025
15:05 PM
26.86% Gain from 52W Low
Volume:
216.2K
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
26 Apr 2023
1482.00
-3.11%
Risk-reward less favorable toward acquisition
Neutral:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 760
Recommendation
Target
Motilal Oswal
Number of FII/FPI investors decreased from 294 to 270 in Jun 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
Market trades higher, Tata Steel's Q1FY26 net profit surges 116.5% YoY to Rs 2,077.7 crore
Trendlyne Marketwatch |
31 Jul 2025, 03:03PM
The twenty year winners among sectoral indices | Screener: Stocks with rising momentum
The Baseline |
31 Jul 2025, 12:23PM
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021